Cargando…
Iroquois Homeobox Protein 2 Identified as a Potential Biomarker for Parkinson’s Disease
The diagnosis of Parkinson’s disease (PD) is initiated after the occurrence of motor symptoms, such as resting tremors, rigidity, and bradykinesia. According to previous reports, non-motor symptoms, notably gastrointestinal dysfunction, could potentially be early biomarkers in PD patients as such sy...
Autores principales: | Sim, Hyuna, Lee, Joo-Eun, Yoo, Hee Min, Cho, Sunwha, Lee, Hana, Baek, Aruem, Kim, Jisun, Seo, Hyemyung, Kweon, Mi-Na, Kim, Hyung Gun, Jeon, Young-Joo, Son, Mi-Young, Kim, Janghwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278941/ https://www.ncbi.nlm.nih.gov/pubmed/32422864 http://dx.doi.org/10.3390/ijms21103455 |
Ejemplares similares
-
Direct Reprogramming to Human Induced Neuronal Progenitors from Fibroblasts of Familial and Sporadic Parkinson’s Disease Patients
por: Lee, Minhyung, et al.
Publicado: (2019) -
Neuroprotective Effects of Cryptotanshinone in a Direct Reprogramming Model of Parkinson’s Disease
por: Lee, Joo-Eun, et al.
Publicado: (2020) -
Quantitative Proteomic Analysis of Primitive Neural Stem Cells from LRRK2 G2019S-Associated Parkinson’s Disease Patient-Derived iPSCs
por: Sim, Hyuna, et al.
Publicado: (2020) -
Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression
por: Ho, Dong Hwan, et al.
Publicado: (2015) -
Correction to: Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression
por: Ho, Dong Hwan, et al.
Publicado: (2017)